Renaissance BioScience Corp., a global leader in yeast bioengineering, announced the appointment of Dr. James Tansey to its Board of Directors, effective immediately. Dr. Tansey brings extensive experience in life sciences, technology commercialization, and corporate governance, which will support the company's development of yeast-produced RNA and virus-like particles (VLPs) for crop protection and potential applications in animal and human health.
Dr. Tansey is a professor at the University of British Columbia's Sauder School of Business and previously taught at Oxford University's Saïd Business School. He is a founding team member at Gemina Labs, where he oversees fundraising, business development, and shareholder strategy. His board experience includes roles at dynaCERT Inc. and Vanadium Resources Ltd., and he serves as a Senior Advisor to InBC, British Columbia's $500 million strategic investment fund.
Maurice Boucher, Renaissance Co-Founder and Executive Chairman, stated: "We are delighted to welcome Dr. Tansey to the Renaissance Board of Directors. James brings an outstanding combination of entrepreneurial, strategic and governance experience, together with a strong track record of helping innovative technology companies grow." Boucher highlighted Tansey's focus on impact investing and environmental sustainability, aligning with Renaissance's mission to address environmental challenges through its technology platforms.
Dr. Tansey commented: "Renaissance has developed an impressive portfolio of innovative technologies with significant commercial potential across agriculture, industrial biotechnology and animal and human health. I look forward to working with the Board and management team to help the company execute on its growth strategy and create long-term value."
Dr. John Husnik, Renaissance Co-Founder, Director and CSO, added: "We are excited to welcome Dr. Tansey to our board. His experience building companies, securing investment, and helping innovative technologies move toward commercialization will complement our scientific expertise and support Renaissance as we continue developing and expanding our leading technology platforms."
Renaissance BioScience is based in Vancouver, Canada, and specializes in yeast bioengineering to provide cost-effective solutions for environmental and industrial challenges in agriculture, food, nutrition, and health. The appointment of Dr. Tansey is expected to strengthen the company's governance as it advances its yeast-based platforms toward global commercialization. For more information, visit www.renaissancebioscience.com.
